STZ-induced type 1 diabetic mice develop allodynia and hyperalgesia.
DPDPE inhibited painful diabetic neuropathy.
CORM-2 and CoPP treatments enhance the antinociceptive effects of DOR agonists.
Heme oxygenase 1 participates in the analgesic effects of DPDPE during diabetes.